Progressive Corporation logo

Progressive Corporation

PGR | NYSE
Chart Builder DCF Calculator
$212.24
-$1.24 (-0.58%)
At close: Sep 21, 2026, 4:00 PM ET
$213
+$0.76 (+0.36%)
Pre-market: Sep 22, 2026, 6:44 AM ET
-0.58%

Rating

Updated: Aug 12, 2026
75.9
Fundamentals Excellent
Market Sentiment Neutral
Moat Wide

Why Price Moved

26 days ago
-2.18%

Shares are trading lower as the company's stock dr...

Key Statistics

Market Data

Market Cap $123.4B
1D Range
211.84 214.12
52W Range
189.20 248.17

Valuation (TTM)

PE 10.64
PB 3.65
EV/EBITDA 8.51

Valuation (NTM)

Forward PE 13.11
Forward PEG -1.07
Price Target $220.75
Loading financial charts...

Profile

The Progressive Corporation, an insurance holding company, offers a comprehensive range of insurance products and associated services across the United States. Its portfolio includes personal and comm...

Employees 70,053
IPO Date Mar 16, 1980
Fiscal Year January - December

Latest News

1 day ago · 247wallst.com

Progressive's Trailing Yield Is Wildly Misleading. Here Is What It Actually Pays
Comparing Progressive (NYSE:PGR) and AON (NYSE:AON)

1 day ago · defenseworld.net

Comparing Progressive (NYSE:PGR) and AON (NYSE:AON)
What History Says About Insurance Stocks When Bond Yields Rise

3 days ago · fool.com

What History Says About Insurance Stocks When Bond Yields Rise
Progressive Reports August 2026 Results

4 days ago · globenewswire.com

Progressive Reports August 2026 Results
Is Progressive Stock a Buy, Sell, or Hold About 10% Below Its 52-Week High?

4 days ago · fool.com

Is Progressive Stock a Buy, Sell, or Hold About 10% Below Its 52-Week High?
Is Most-Watched Stock The Progressive Corporation (PGR) Worth Betting on Now?

5 days ago · zacks.com

Is Most-Watched Stock The Progressive Corporation (PGR) Worth Betting on Now?
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer's Disease

6 days ago · globenewswire.com

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer's Disease
Progressive (PGR) Gains As Market Dips: What You Should Know

8 days ago · zacks.com

Progressive (PGR) Gains As Market Dips: What You Should Know
Can PGR's Telematics Edge Strengthen Its Underwriting Advantage?

13 days ago · zacks.com

Can PGR's Telematics Edge Strengthen Its Underwriting Advantage?
Progressive (PGR) Outperforms Broader Market: What You Need to Know

19 days ago · zacks.com

Progressive (PGR) Outperforms Broader Market: What You Need to Know

Earnings

Next Earnings
Oct 21, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
16
Consensus
Hold
Price Target
$228
Upside
+7.43%
Buy (6)
Hold (7)
Sell (1)
Analyst Details

© 2026 bestshares.com. All rights reserved.